Page last updated: 2024-10-25

citalopram and Amyloid Deposits

citalopram has been researched along with Amyloid Deposits in 4 studies

Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.

Research Excerpts

ExcerptRelevanceReference
"We performed in vivo microdialysis and in vivo 2-photon imaging to assess changes in brain interstitial fluid (ISF) Aβ and Aβ plaque size over time, respectively, in the APP/presenilin 1 mouse model of Alzheimer disease treated with vehicle or escitalopram."3.96Effect of escitalopram on Aβ levels and plaque load in an Alzheimer mouse model. ( Cirrito, JR; Davis, TA; Doherty, BM; Gardiner, WD; King, D; Lee, JM; Sheline, YI; Wallace, CE; Yan, P; Yuede, CM, 2020)
" In healthy human volunteers, citalopram's effects on Aβ production and Aβ concentrations in cerebrospinal fluid (CSF) were measured prospectively using stable isotope labeling kinetics, with CSF sampling during acute dosing of citalopram."2.79An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice. ( Bateman, RJ; Chott, R; Cirrito, JR; Ficker, WD; Fisher, JR; Frederiksen, C; Grzelak, MV; Jasielec, MS; Lee, JM; Mintun, MA; Morris, JC; Sheline, YI; Swarm, R; West, T; Xiong, C; Yan, P; Yarasheski, K, 2014)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Cirrito, JR2
Wallace, CE1
Yan, P2
Davis, TA1
Gardiner, WD1
Doherty, BM1
King, D1
Yuede, CM1
Lee, JM2
Sheline, YI2
Zhang, Q1
Yang, C1
Liu, T1
Liu, L1
Li, F1
Cai, Y1
Lv, K1
Li, X1
Gao, J1
Sun, D1
Xu, H1
Yang, Q1
Fan, X1
West, T1
Yarasheski, K1
Swarm, R1
Jasielec, MS1
Fisher, JR1
Ficker, WD1
Xiong, C1
Frederiksen, C1
Grzelak, MV1
Chott, R1
Bateman, RJ1
Morris, JC1
Mintun, MA1
Holm, P1
Ettrup, A1
Klein, AB1
Santini, MA1
El-Sayed, M1
Elvang, AB1
Stensbøl, TB1
Mikkelsen, JD1
Knudsen, GM1
Aznar, S1

Trials

1 trial available for citalopram and Amyloid Deposits

ArticleYear
An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice.
    Science translational medicine, 2014, May-14, Volume: 6, Issue:236

    Topics: Adult; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antidepressive Agents; Brain; Cit

2014

Other Studies

3 other studies available for citalopram and Amyloid Deposits

ArticleYear
Effect of escitalopram on Aβ levels and plaque load in an Alzheimer mouse model.
    Neurology, 2020, 11-10, Volume: 95, Issue:19

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Citalopram

2020
Citalopram restores short-term memory deficit and non-cognitive behaviors in APP/PS1 mice while halting the advance of Alzheimer's disease-like pathology.
    Neuropharmacology, 2018, 03-15, Volume: 131

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cerebral Cortex;

2018
Plaque deposition dependent decrease in 5-HT2A serotonin receptor in AbetaPPswe/PS1dE9 amyloid overexpressing mice.
    Journal of Alzheimer's disease : JAD, 2010, Volume: 20, Issue:4

    Topics: Aging; Amphetamines; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Autoradiography; Ci

2010